Windlas Biotech IPO Subscription Status
Windlas Biotech IPO was subscribed 22.53 times when bidding closed on 6 Aug 2021: QIB 24.1x, NII 15.91x, Retail 24.48x.
The Windlas Biotech IPO has been subscribed 22.53x times overall. Retail investors have shown interest with bids for 24.48x the shares available. The Non-Institutional Investor (NII) category has been subscribed 15.91x. Qualified Institutional Buyers (QIBs) have subscribed 24.1x. Data last updated on 10 Nov, 07:18 AM.
The IPO subscription period has ended. Given the strong demand, the allotment process is expected to be highly competitive. The issue opened on 04 Aug, 2021 and closes on 06 Aug, 2021. The shares are expected to list on stock exchanges on 16 Aug, 2021.
Researched & reviewed by
Abhishek Vohera,
Founder, IPO Guru
Last updated
Figures sourced from the RHP, BSE & NSE
Live bidding
Shares bid against shares offered, category by category, as published by the exchanges. Summary splits NII into bHNI (above ₹10 lakh) and sHNI (₹2–10 lakh); switch to Detailed for the exchange's own sub-category rows.
| Category | Bid details | Times |
|---|---|---|
| QIB | - of - - | 24.1x |
| NII | - of - - | 15.91x |
| Retail | - of - - | 24.48x |
| TOTAL | - - | 22.53x |
Windlas Biotech IPO allotment probability
Your odds of an allotment in each category at the current subscription.
Odds = allotment slots ÷ applications, or the subscription multiple where counts aren't available. Retail and HNI allotment is by lottery; QIB is proportionate. Not investment advice.
Subscription insights
What the current book is saying, read off the category numbers above.
Retail Allotment
High demand detected. The retail category is heavily oversubscribed, making the allotment a lottery where only 1 out of every 25 applicants will be successful.
Institutional Backing
Massive institutional interest with QIBs subscribing 24.1x. This often signals long-term confidence from professional funds.
Day-wise subscription history
End-of-day subscription across the 3-day bidding window. On phones, tap a day for the category split.
| Date | Total | ||
|---|---|---|---|
|
06 Aug 2021
Day 3 |
22.53x | ▼ | |
|
QIB24.1x
BHNI-
SHNI-
Retail24.48x
|
|||
|
05 Aug 2021
Day 2 |
7x | ▼ | |
|
QIB0.04x
BHNI-
SHNI-
Retail13.4x
|
|||
|
04 Aug 2021
Day 1 |
3.18x | ▼ | |
|
QIB-
BHNI-
SHNI-
Retail6.22x
|
|||
Windlas Biotech IPO dates
From the bidding window to listing. Today is 14 November.
- Open 04 Aug 2021
- Close 06 Aug 2021
- Allotment 11 Aug 2021
- Refund/credit 12 Aug 2021
- Listing 16 Aug 2021
Anchor investor allocation
Shares allotted to anchor investors the working day before the issue opened.
What does this subscription data mean?
IPO subscription data tells you how much demand exists for the shares being offered, broken down by investor category. Understanding each category helps you gauge the real sentiment behind the numbers:
- 01 QIB (Qualified Institutional Buyers) — includes mutual funds, FIIs, insurance companies, and banks. QIBs do deep due diligence before bidding. A QIB subscription above 10x is a strong institutional endorsement. Watch QIB numbers closely on the final day — they often hold back and flood in after 3 PM.
- 02 NII / HNI (Non-Institutional Investors) — high-net-worth individuals bidding above ₹2 lakh. NII allotment is proportionate (not lottery), so higher NII subscription means smaller per-lot allotment. Big HNI (B-HNI) bids above ₹10 lakh; Small HNI (S-HNI) bids ₹2–10 lakh.
- 03 Retail — individual investors bidding up to ₹2 lakh. When retail is below 1x, everyone who applied gets full allotment. When oversubscribed, SEBI mandates a computerised lottery — only 1 lot per successful applicant regardless of how many lots you apply for.
- 04 Overall Subscription — a blended multiple across all categories. A total subscription above 10x is considered strong; above 50x is exceptional and usually predicts strong listing gains.
Data sourced from BSE/NSE. Subscription numbers are updated during bidding hours (10 AM – 5 PM IST) on active subscription days.
Frequently asked
What is the current subscription status of Windlas Biotech IPO?
As of IPO close date (06 Aug, 2021), the Windlas Biotech IPO is subscribed 22.53x times. Retail category is 24.48x, and NII is 15.91x subscribed.
When is the allotment date for Windlas Biotech IPO?
The allotment for Windlas Biotech IPO is expected to be finalized on 11 August, 2021.
What is the GMP of Windlas Biotech?
The Grey Market Premium (GMP) for Windlas Biotech is currently ₹120, indicating a potential listing gain of 26%.
When will Windlas Biotech IPO list on the stock market?
Windlas Biotech is scheduled to list on BSE and NSE on 16 August, 2021.
What are the chances of getting allotment in Windlas Biotech IPO?
The retail category is oversubscribed at 24.48x, meaning allotment is by lottery. Statistically, approximately 1 in 25 applicants will receive allotment. Applying with multiple family member accounts (each at minimum lot size) improves your cumulative odds.
What does QIB subscription of 24.1x mean for Windlas Biotech IPO?
Strong — QIBs (mutual funds, FIIs, insurance companies) have subscribed 24.1x, indicating high institutional conviction. Heavy QIB demand is historically one of the strongest predictors of a positive listing.
How to check Windlas Biotech IPO allotment status?
After the allotment date (11 Aug, 2021), you can check your Windlas Biotech IPO allotment status on IPO Guru's allotment checker, on the BSE/NSE website using your PAN or application number, or through your broker's app.
Explore Windlas Biotech IPO further
Track every stage of this IPO, from subscription to listing.
It has listed — go back to the fundamentals.
Live grey market premium, Kostak and Subject to Sauda, with the day-wise trend.
What brokers and analysts are saying about this issue, in one place.
Check with your PAN whether shares were credited to your demat account.
Subscription moves by the hour. Get it on your phone.
Live GMP alerts, subscription updates and allotment status for every Mainboard and SME issue — fast, free and secure.
Not investment advice. Subscription figures are as published by BSE/NSE and change until bidding closes.
